ID

26601

Descripción

A Study of Circulating Endothelial Cell as Marker for Avastin (Bevacizumab) in Combination With Docetaxel Plus Xeloda (Capecitabine) as First Line Treatment for Patients With Locally Recurrent and Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00845910

Link

https://clinicaltrials.gov/show/NCT00845910

Palabras clave

Versiones (1)
  1. 21/10/17 21/10/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

21 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT00845910

Inglés

Eligibility Breast Cancer NCT00845910

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients, 18-65 years of age;
Descripción

Gender | Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
locally recurrent and metastatic breast cancer;
Descripción

Breast cancer recurrent Local | Secondary malignant neoplasm of female breast

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0278493
UMLS CUI [1,2]
C0205276
UMLS CUI [2]
C0346993
measurable or evaluable disease;
Descripción

Measurable Disease | Evaluable Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
ecog performance status of 0-2;
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
lvef >=50% without clinical symptoms or signs of heart failure.
Descripción

Left ventricular ejection fraction | Sign or Symptom Absent Heart failure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428772
UMLS CUI [2,1]
C3540840
UMLS CUI [2,2]
C0332197
UMLS CUI [2,3]
C0018801
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
unknown her2 status, or known her2-positive status;
Descripción

HER2/Neu Status Unknown | HER2/Neu Positive

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348910
UMLS CUI [2]
C2348909
prior chemotherapy for locally recurrent or metastatic disease;
Descripción

Chemotherapy Recurrent disease Local | Chemotherapy Neoplasm Metastasis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0277556
UMLS CUI [1,3]
C0205276
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0027627
prior adjuvant or neoadjuvant taxane therapy within 12 months prior to start of treatment;
Descripción

Taxane Adjuvant therapy | Taxane Neoadjuvant Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0215136
UMLS CUI [1,2]
C0677850
UMLS CUI [2,1]
C0215136
UMLS CUI [2,2]
C0600558
clinical or radiological evidence of cns metastases;
Descripción

CNS metastases Evidence of

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0332120
clinically significant cardiovascular disease.
Descripción

Cardiovascular Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007222
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT00845910

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
female patients, 18-65 years of age;
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Breast cancer recurrent Local | Secondary malignant neoplasm of female breast
Item
locally recurrent and metastatic breast cancer;
boolean
C0278493 (UMLS CUI [1,1])
C0205276 (UMLS CUI [1,2])
C0346993 (UMLS CUI [2])
Measurable Disease | Evaluable Disease
Item
measurable or evaluable disease;
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
ECOG performance status
Item
ecog performance status of 0-2;
boolean
C1520224 (UMLS CUI [1])
Left ventricular ejection fraction | Sign or Symptom Absent Heart failure
Item
lvef >=50% without clinical symptoms or signs of heart failure.
boolean
C0428772 (UMLS CUI [1])
C3540840 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0018801 (UMLS CUI [2,3])
Item Group
C0680251 (UMLS CUI)
HER2/Neu Status Unknown | HER2/Neu Positive
Item
unknown her2 status, or known her2-positive status;
boolean
C2348910 (UMLS CUI [1])
C2348909 (UMLS CUI [2])
Chemotherapy Recurrent disease Local | Chemotherapy Neoplasm Metastasis
Item
prior chemotherapy for locally recurrent or metastatic disease;
boolean
C0392920 (UMLS CUI [1,1])
C0277556 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C0027627 (UMLS CUI [2,2])
Taxane Adjuvant therapy | Taxane Neoadjuvant Therapy
Item
prior adjuvant or neoadjuvant taxane therapy within 12 months prior to start of treatment;
boolean
C0215136 (UMLS CUI [1,1])
C0677850 (UMLS CUI [1,2])
C0215136 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
CNS metastases Evidence of
Item
clinical or radiological evidence of cns metastases;
boolean
C0686377 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
Cardiovascular Disease
Item
clinically significant cardiovascular disease.
boolean
C0007222 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial